{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:49:10Z","timestamp":1792756150038,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ21C100002"],"award-info":[{"award-number":["LQ21C100002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011332","name":"University of Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["WIUCASQD2019009"],"award-info":[{"award-number":["WIUCASQD2019009"]}],"id":[{"id":"10.13039\/501100011332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2020KY360"],"award-info":[{"award-number":["2020KY360"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.actbio.2022.09.029","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T11:34:25Z","timestamp":1663414465000},"page":"231-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Decorating hexahistidine-metal assemblies with tyrosine enhances the ability of proteins to pass through corneal biobarriers"],"prefix":"10.1016","volume":"153","author":[{"given":"Bojiao","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronggui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinxiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjie","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.actbio.2022.09.029_bib0001","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.201900148","article-title":"Glucose and pH dual-responsive nanogels for efficient protein delivery","volume":"19","author":"Si","year":"2019","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.actbio.2022.09.029_bib0002","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.actbio.2021.05.001","article-title":"Efficient delivery of cytosolic proteins by protein-hexahistidine-metal co-assemblies","volume":"129","author":"Huang","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2022.09.029_bib0003","unstructured":"Protein therapeutics market, BBC research, 2022 https:\/\/www.alliedmarketresearch.com\/protein-therapeutics-market."},{"issue":"1","key":"10.1016\/j.actbio.2022.09.029_bib0004","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1432-1033.1997.00080.x","article-title":"Dynamic structure\/function relationships in the alpha-chymotrypsin deactivation process by heat and pH","volume":"248","author":"Lozano","year":"1997","journal-title":"Eur. J. Biochem."},{"issue":"21","key":"10.1016\/j.actbio.2022.09.029_bib0005","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1039\/D0BM01151G","article-title":"Nano and microscale delivery platforms for enhanced oral peptide\/protein bioavailability","volume":"8","author":"Tong","year":"2020","journal-title":"Biomater. Sci."},{"issue":"sup1","key":"10.1016\/j.actbio.2022.09.029_bib0006","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/21691401.2018.1430695","article-title":"Passive delivery of protein drugs through transdermal route","volume":"46","author":"Chaulagain","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"1","key":"10.1016\/j.actbio.2022.09.029_bib0007","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijpharm.2017.09.027","article-title":"A comprehensive screening platform for aerosolizable protein formulations for intranasal and pulmonary drug delivery","volume":"532","author":"Rohm","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.actbio.2022.09.029_bib0008","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/156720112801323125","article-title":"Controlled and continuous release ocular drug delivery systems: pros and cons","volume":"9","author":"Abdelkader","year":"2012","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.actbio.2022.09.029_bib0009","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.addr.2018.01.008","article-title":"Ocular delivery of proteins and peptides: challenges and novel formulation approaches","volume":"126","author":"Mandal","year":"2018","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"12","key":"10.1016\/j.actbio.2022.09.029_bib0010","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/js9802594","article-title":"Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye","volume":"87","author":"Prausnitz","year":"1998","journal-title":"J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.actbio.2022.09.029_bib0011","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3390\/pharmaceutics12121232","article-title":"Biodegradable nanoparticle for cornea drug delivery: focus review","volume":"12","author":"Mobaraki","year":"2020","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.actbio.2022.09.029_bib0012","first-page":"444","article-title":"Corneal neovascularization and biological therapy","volume":"8","author":"Voiculescu","year":"2015","journal-title":"J. Med. Life"},{"key":"10.1016\/j.actbio.2022.09.029_bib0013","first-page":"264","article-title":"Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American ophthalmological society thesis)","volume":"104","author":"Azar","year":"2006","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.actbio.2022.09.029_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102017","article-title":"Bevacizumab (Avastin(R)) in cancer treatment: a review of 15 years of clinical experience and future outlook","volume":"86","author":"Garcia","year":"2020","journal-title":"Cancer Treat. Rev."},{"issue":"6","key":"10.1016\/j.actbio.2022.09.029_bib0015","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.actbio.2022.09.029_bib0016","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbrc.2005.05.132","article-title":"Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy","volume":"333","author":"Ferrara","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.actbio.2022.09.029_bib0017","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.addr.2017.04.001","article-title":"Nanoparticles for drug delivery to the anterior segment of the eye","volume":"122","author":"Janagam","year":"2017","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"1","key":"10.1016\/j.actbio.2022.09.029_bib0018","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/pharmaceutics10010028","article-title":"Ocular drug delivery barriers-role of nanocarriers in the treatment of anterior segment ocular diseases","volume":"10","author":"Bachu","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.actbio.2022.09.029_bib0019","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.actbio.2020.01.008","article-title":"Multifunctional carboxymethyl chitosan derivatives-layered double hydroxide hybrid nanocomposites for efficient drug delivery to the posterior segment of the eye","volume":"104","author":"Wang","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2022.09.029_bib0020","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.preteyeres.2013.04.001","article-title":"Nanomedicines for back of the eye drug delivery, gene delivery, and imaging","volume":"36","author":"Kompella","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.actbio.2022.09.029_bib0021","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2014.05.031","article-title":"Nanotherapy for posterior eye diseases","volume":"193","author":"Kaur","year":"2014","journal-title":"J. Control. Release"},{"issue":"1-2","key":"10.1016\/j.actbio.2022.09.029_bib0022","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-5173(01)00760-8","article-title":"Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A","volume":"224","author":"De Campos","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2022.09.029_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120405","article-title":"Cell penetrating peptide TAT-functionalized liposomes for efficient ophthalmic delivery of flurbiprofen: Penetration and its underlying mechanism, retention, anti-inflammation and biocompatibility","volume":"598","author":"Wu","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.actbio.2022.09.029_bib0024","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/17425247.2020.1698544","article-title":"Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier","volume":"17","author":"Tosi","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"issue":"2","key":"10.1016\/j.actbio.2022.09.029_bib0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1055\/a-1290-0119","article-title":"Design, synthesis and enhanced BBB penetration studies of L-serine-tethered nipecotic acid-prodrug","volume":"71","author":"Dhanawat","year":"2021","journal-title":"Drug Res."},{"key":"10.1016\/j.actbio.2022.09.029_bib0026","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.actbio.2017.09.023","article-title":"Discerning the composition of penetratin for safe penetration from cornea to retina","volume":"63","author":"Jiang","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2022.09.029_bib0027","unstructured":"X. Liu, Z. Zhao, L. Yin, Carrier-free protein intracellular delivery prodrug useful in preparation of protein drugs or anti-tumor drugs which does not contain polymer materials, comprises protein, monomer structure covalently connected to protein and LAT1 substrate molecule, Univ Soochow (Uswz-C), pp. CN113599504-A."},{"key":"10.1016\/j.actbio.2022.09.029_bib0028","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.actbio.2018.08.023","article-title":"Metal-organic frameworks, NH2-MIL-88(Fe), as carriers for ophthalmic delivery of brimonidine","volume":"79","author":"Kim","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2022.09.029_bib0029","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.actbio.2019.03.058","article-title":"Hexahistidine-metal assemblies: a promising drug delivery system","volume":"90","author":"Huang","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2022.09.029_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2014.02.005","article-title":"Alkali burn versus suture-induced corneal neovascularization in C57BL\/6 mice: an overview of two common animal models of corneal neovascularization","volume":"121","author":"Giacomini","year":"2014","journal-title":"Exp. Eye Res."},{"issue":"11","key":"10.1016\/j.actbio.2022.09.029_bib0031","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1096\/fj.201700336R","article-title":"Animal models of ocular angiogenesis: from development to pathologies","volume":"31","author":"Liu","year":"2017","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.actbio.2022.09.029_bib0033","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/10717544.2021.1872739","article-title":"Ocular lamellar crystalline gels for sustained release and enhanced permeation of resveratrol against corneal neovascularization","volume":"28","author":"Li","year":"2021","journal-title":"Drug Deliv."},{"issue":"8","key":"10.1016\/j.actbio.2022.09.029_bib0034","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/smll.201303433","article-title":"Topical delivery of avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes","volume":"10","author":"Davis","year":"2014","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.actbio.2022.09.029_bib0032","doi-asserted-by":"crossref","first-page":"e15905","DOI":"10.1371\/journal.pone.0015905","article-title":"A novel peptide derived from human apolipoprotein E is an inhibitor of tumor growth and ocular angiogenesis","volume":"6","author":"Lewin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.actbio.2022.09.029_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105592","article-title":"In vitro angiogenesis inhibition with selective compounds targeting the key glycolytic enzyme PFKFB3","volume":"168","author":"Abdali","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.actbio.2022.09.029_bib0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/19336896.2019.1704612","article-title":"Proteinase K resistant cores of prions and amyloids","volume":"14","author":"Kushnirov","year":"2020","journal-title":"Prion"},{"issue":"4","key":"10.1016\/j.actbio.2022.09.029_bib0037","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.7150\/thno.30056","article-title":"Tumor-secreted dickkopf2 accelerates aerobic glycolysis and promotes angiogenesis in colorectal cancer","volume":"9","author":"Deng","year":"2019","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.actbio.2022.09.029_bib0038","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201700455","article-title":"Nanomicelle-assisted targeted ocular delivery with enhanced antiinflammatory efficacy in vivo","volume":"5","author":"Weng","year":"2018","journal-title":"Adv. Sci."},{"key":"10.1016\/j.actbio.2022.09.029_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.107977","article-title":"Corneal neovascularization is inhibited with nucleolin-binding aptamer, AS1411","volume":"193","author":"Vivanco-Rojas","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.actbio.2022.09.029_bib0040","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ebiom.2019.05.026","article-title":"Three kinds of corneal host cells contribute differently to corneal neovascularization","volume":"44","author":"Yu","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.actbio.2022.09.029_bib0041","doi-asserted-by":"crossref","first-page":"15","DOI":"10.22336\/rjo.2019.4","article-title":"Corneal neovascularization: updates on pathophysiology, investigations & management","volume":"63","author":"Sharif","year":"2019","journal-title":"Rom. J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.actbio.2022.09.029_bib0042","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1172\/JCI126655","article-title":"Roles of HIFs and VEGF in angiogenesis in the retina and brain","volume":"129","author":"Rattner","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.actbio.2022.09.029_bib0043","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s41232-021-00166-7","article-title":"VEGFR1-tyrosine kinase signaling in pulmonary fibrosis","volume":"41","author":"Amano","year":"2021","journal-title":"Inflamm. Regen."},{"issue":"1","key":"10.1016\/j.actbio.2022.09.029_bib0044","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.colsurfb.2007.06.013","article-title":"The expression patterns of vascular endothelial growth factor and thrombospondin 2 after corneal alkali burn","volume":"60","author":"Yan","year":"2007","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"4","key":"10.1016\/j.actbio.2022.09.029_bib0045","doi-asserted-by":"crossref","first-page":"e94205","DOI":"10.1371\/journal.pone.0094205","article-title":"Mechanisms controlling the effects of bevacizumab (avastin) on the inhibition of early but not late formed corneal neovascularization","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706122005918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706122005918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:01:09Z","timestamp":1761674469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706122005918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":45,"alternative-id":["S1742706122005918"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2022.09.029","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decorating hexahistidine-metal assemblies with tyrosine enhances the ability of proteins to pass through corneal biobarriers","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2022.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}